Pharmacologic Management of Stump Pain

Assessment and Pain Classification

Stump pain typically comprises both nociceptive (tissue injury) and neuropathic (nerve damage) components, necessitating a dual‑mechanism treatment approach rather than monotherapy. 3

Acetaminophen is the preferred initial analgesic for the nociceptive component because it avoids the gastrointestinal bleeding, renal toxicity, and cardiovascular risks associated with NSAIDs. 1
Recommended dosing: 650–1,000 mg every 6–8 hours, not exceeding 4,000 mg per 24 hours; for patients ≥ 60 years, the maximum daily dose should be reduced to 3,000 mg to lower hepatotoxicity risk. 1
Patients should be counseled explicitly to avoid any additional acetaminophen‑containing products (e.g., combination cold remedies) to prevent inadvertent overdose. 1, 4
If acetaminophen alone provides insufficient relief, add a topical NSAID (diclofenac gel applied three times daily or a 180 mg diclofenac patch once or twice daily) for localized pain relief with minimal systemic absorption. 2, 4

Gabapentin is the first‑line adjuvant for neuropathic stump pain and should be used in combination with acetaminophen, not as monotherapy. 2, 5
Initiate gabapentin at 100–300 mg at bedtime; titrate by 50–100 % every few days as tolerated to a target dose of 900–3,600 mg daily divided into 2–3 doses. 2, 5
Employ slower titration and lower target doses in elderly or medically frail patients, and adjust dosing for renal insufficiency based on creatinine clearance. 2
Pregabalin is an alternative: start 50 mg three times daily, increase to 100 mg three times daily, with a maximum of 600 mg per day, following similar titration principles. 2, 5

Tricyclic antidepressants (TCAs) such as nortriptyline or desipramine are preferred over amitriptyline because they are better tolerated while maintaining analgesic efficacy. Initiate at 10–25 mg nightly, titrate every 3–5 days, and aim for 50–150 mg nightly; analgesic effect occurs at lower doses and precedes antidepressant activity. 2, 5
Duloxetine (30–60 mg daily, titrate to 60–120 mg) and venlafaxine (50–75 mg daily, titrate to 75–225 mg) are additional oral agents for neuropathic pain. 2

A lidocaine 5 % patch applied daily to the stump provides localized analgesia with minimal systemic absorption and can be combined with oral medications. 2, 4

For opioid‑naïve patients with mild pain (numeric rating 1–3/10), exhaust all non‑opioid options (acetaminophen, adjuvants, topical agents) before initiating opioids. 6, 7
For moderate pain (rating 4–7/10) unresponsive to optimized non‑opioid therapy, short‑acting opioids may be considered after full optimization of the multimodal regimen. 6, 7
Tramadol (12.5–25 mg every 4–6 hours) offers dual‑mechanism analgesia but carries seizure risk at high doses and potential serotonin syndrome when combined with SSRIs. 8

Liver enzymes (AST/ALT) should be monitored regularly in patients on long‑term acetaminophen, especially when dosing approaches the maximum daily limit. 1
Pain intensity must be reassessed at each clinical encounter using a numeric rating scale to ensure therapeutic goals are met. 6, 7
Renal function should be evaluated before prescribing gabapentin or pregabalin, with dose adjustments made according to creatinine clearance. 2

NSAIDs should not be used as first‑line therapy in elderly patients, those with renal impairment, cardiovascular disease, or gastrointestinal bleeding risk; acetaminophen is the safer alternative. 8, 4
Treating stump pain with acetaminophen alone is insufficient; the neuropathic component requires adjuvant therapy such as gabapentin, pregabalin, or TCAs. 2
Opioids should not be escalated without first optimizing a multimodal non‑opioid regimen (acetaminophen + gabapentin/pregabalin + topical agents). 6
First‑line TCAs should be secondary‑amine agents (nortriptyline, desipramine) rather than tertiary‑amine agents (amitriptyline, imipramine) due to a more favorable tolerability profile. 2